In 2022, the most common comorbidity among people treated for neurotic and mood disorders in France was another psychiatric illness and especially addictive disorders. The prevalence of another psychiatric illness among people treated for neurotic and mood disorders reached 26 percent during that year. That year, treatment of vascular risk was the second most common comorbidity for people with such a disorder in France.
Share of people treated for neurotic and mood disorders with at least one other pathology in France in 2022, by comorbidity
comorbidities
Share of patients
Another psychiatric illness*
26%
Treatment of vascular risk
22%
Cardiovascular disease
18%
Diabetes
13%
Chronic respiratory disease
13%
Neurological or degenerative disease
12%
Cancer
10%
Another long term pathology
7%
Inflammatory, rare disease, or HIV
4%
Liver or pancreas disease
3%
Created with Highcharts 7.2.2comorbiditiesShare of patients26%26%22%22%18%18%13%13%13%13%12%12%10%10%7%7%4%4%3%3%Anotherpsychiatric illness*Treatment ofvascular riskCardiovasculardiseaseDiabetesChronicrespiratorydiseaseNeurological ordegenerativediseaseCancerAnother long termpathologyInflammatory, raredisease, or HIVLiver or pancreasdisease
0%5%10%15%20%25%30%
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
CNAM, & Ameli. (July 1, 2024). Share of people treated for neurotic and mood disorders with at least one other pathology in France in 2022, by comorbidity [Graph]. In Statista. Retrieved March 05, 2025, from https://www.statista.com/statistics/1289796/share-of-people-treated-for-neurotic-and-mood-disorders-with-another-pathology-in-france-by-comorbidity/
CNAM, und Ameli. "Share of people treated for neurotic and mood disorders with at least one other pathology in France in 2022, by comorbidity." Chart. July 1, 2024. Statista. Accessed March 05, 2025. https://www.statista.com/statistics/1289796/share-of-people-treated-for-neurotic-and-mood-disorders-with-another-pathology-in-france-by-comorbidity/
CNAM, Ameli. (2024). Share of people treated for neurotic and mood disorders with at least one other pathology in France in 2022, by comorbidity. Statista. Statista Inc.. Accessed: March 05, 2025. https://www.statista.com/statistics/1289796/share-of-people-treated-for-neurotic-and-mood-disorders-with-another-pathology-in-france-by-comorbidity/
CNAM, and Ameli. "Share of People Treated for Neurotic and Mood Disorders with at Least One Other Pathology in France in 2022, by Comorbidity." Statista, Statista Inc., 1 Jul 2024, https://www.statista.com/statistics/1289796/share-of-people-treated-for-neurotic-and-mood-disorders-with-another-pathology-in-france-by-comorbidity/
CNAM & Ameli, Share of people treated for neurotic and mood disorders with at least one other pathology in France in 2022, by comorbidity Statista, https://www.statista.com/statistics/1289796/share-of-people-treated-for-neurotic-and-mood-disorders-with-another-pathology-in-france-by-comorbidity/ (last visited March 05, 2025)
Share of people treated for neurotic and mood disorders with at least one other pathology in France in 2022, by comorbidity [Graph], CNAM, & Ameli, July 1, 2024. [Online]. Available: https://www.statista.com/statistics/1289796/share-of-people-treated-for-neurotic-and-mood-disorders-with-another-pathology-in-france-by-comorbidity/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.